Formulary Monographs [STREPTOKINASE, 201220]
|
|
STREPTOKINASE
|
|
|
|
|
|
THROMBOLYTIC AGENTS
|
|
|
Thromboembolic disorders.
|
|
|
Haemorrhage, allergic reactions, rare- Guillain-Barre syndrome.
Due to risk of anaphylaxis, repeated use is contraindicated. |
|
|
1.5 million units infused over 1 hour as soon as possible after the onset of symptoms. Pulmonary embolism and other arteriovenous occlusions: an initial loading dose of 250 000 units infused intravenously over 30 minutesfollowed by a maintenance dos
|
|
|
|
|
|
Avoid use during pregnancy.
|
|
|
|
|
|
|